You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Controlled Ethanol Cell Culture System
SBC: GINER INC Topic: N/ADESCRIPTION (provided by applicant): Controlled exposure of primary and cultured cells to ethanol is an important experimental aspect of current biomolecular level research for the treatment of alcohol use disorders such as alcohol dependence and alcoh
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
PORTABLE ISLET CULTURE SYS
SBC: GINER INC Topic: N/AN/A
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
PORTABLE ISLET CULTURE SYS
SBC: GINER INC Topic: N/AN/A
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Direct Methanol Fuel Cells for Wheelchair Applications
SBC: GINER INC Topic: N/ADESCRIPTION (provided by applicant): The development of a lightweight power supply, based on direct methanol fuel cell (DMFC) technology, for use in a powered pediatric mobility device is proposed. The fuel cell system would replace the lead acid batte
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Cylinder-Free Atmosphere Control for Incubators
SBC: GINER INC Topic: N/ADESCRIPTION (provided by applicant): In this Phase I SBIR program, the feasibility of a novel electrochemical oxygen and carbon dioxide control system, providing variable, cylinder-free, incubator control will be demonstrated by Giner, Inc. The goal is
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Fluorosome Technique for Drug Permeability Studies
SBC: GLSynthesis Inc. Topic: N/ADESCRIPTION (provided by applicant): We have validated a novel method, the "Fluorosome-trans Technique", to measure membrane permeabilities of drugs. The results for 47-marketed drugs show high correlation with human oral absorption. This method empl
SBIR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health -
Non-Sedating Atropisomeric Drugs for Atopic Disease
SBC: GLSynthesis Inc. Topic: N/ADESCRIPTION (provided by applicant): The present project's goal is to develop oral medications for the treatments of atopic dermatitis, asthma and allergic rhinitis. SAR studies have produced two lead compounds that show increased potency and markedly
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
CD137 AS A TARGET FOR THE IMMUNOTHERAPY OF CANCER
SBC: GTC BIOTHERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The objective of this proposal is to establish the feasibility of producing anti-human CD137 antibody, an immune modulator that may be effective against solid tumors, in the milk of transgenic animals. CD137 (also call
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Improved yield of human albumin from transgenic cow milk
SBC: GTC BIOTHERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The overall goal of this program is to provide an abundant, cost-effective, biosecure source of human albumin for human therapeutic use by producing recombinant human albumin (rhA) in the milk of transgenic cows.
SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health -
Nuclear Transfer Embryos from Tetraploid Embryos
SBC: GTC BIOTHERAPEUTICS, INC. Topic: N/ADESCRIPTION (provided by applicant): The objective of this proposal is to produce tetraploid embryos for aggregation with nuclear transfer embryos for the production of transgenic cattle and goats. GTC Biotherapeutics (formerly Genzyme Transgenics Corporation) has developed the expression of recombinant proteins in the milk of transgenic dairy animals. The milk of transgenic goats and cattle is a ...
STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health